Nicotine Gum Market Report by Type, Application, Distribution Channel, and Region 2025-2033
상품코드:1792427
리서치사:IMARC
발행일:2025년 08월
페이지 정보:영문 141 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 니코틴 껌 시장 규모는 2024년 17억 달러에 달했습니다. IMARC Group은 향후 2025-2033년 4%의 성장률(CAGR)로 성장할 전망이며, 2033년에는 25억 달러에 달할 것으로 예측했습니다. 세계 시장의 성장 요인으로는 금연 노력 및 건강 의식 증가, 편리한 OTC 니코틴 대체 요법에 대한 수요 증가 등 다양한 것들이 있습니다. 또한 제품의 효율성을 높이는 기술 혁신도 시장에 큰 부가가치를 부여하고 있습니다.
니코틴 껌 시장 분석 :
주요 시장 성장 촉진요인 : 흡연과 관련된 건강 위험에 대한 인식 증 및 세계 금연에 대한 다양한 노력이 성장 촉진요인으로 작용하고 있습니다.
주요 시장 동향 : 시판(OTC) 니코틴 대체 요법에 대한 수요가 증가하고 있습니다. 이는 금연을 목표로 하는 사람들 사이에서 제품의 편의성 및 가용성이 향상됨에 따라 시장의 성장을 뒷받침하고 있습니다.
지리적 동향 : 보고서에 따르면 북미는 건강 지향 소비자 증가로 시장에서 주도적인 지위를 차지합니다.
경쟁 구도 : 주요 기업은 British American Tobacco, Cambrex Corporation, GlaxoSmithKline, ITC Limited, Johnson & Johnson Services, Novartis, Perrigo, Pfizer, Takeda Pharmaceutical Company 등입니다.
과제 및 기회 : 과제는 금연 보조제와 관련된 사회적 스티그마를 극복하고 금연 과정에서 니코틴 껌의 역할에 대해 적절한 교육을 해야 합니다. 그럼에도 불구하고, 니코틴 껌 시장의 최근 비즈니스 기회는 흡연과 관련된 건강 문제를 해결하기 위한 기술의 발전과 기업 간의 협업을 포함합니다.
니코틴 껌 시장 동향 :
금연 활동 및 건강 의식
흡연을 줄이기 위한 세계의 노력이 건강 의식 고조와 함께 시장 확대를 뒷받침하고 있습니다. 흡연과 관련된 건강 위험에 대한 인식이 높아지는 가운데 사람들은 금연을 위한 효과적인 전략을 적극적으로 모색하고 있습니다. 니코틴 껌은 니코틴을 서서히 방출하여 금단 증상을 조절하는 금연 보조제입니다. 또한 헬스케어 기관과 규제 당국의 다양한 금연 프로그램이 니코틴 껌 수요에 유리하게 작용하고 있습니다. 공중 보건의 중요성과 금연에 대한 지속적인 노력으로 금연 치료에 필수적인 요소로 이 껌이 받아들여지고 있는 것이 시장 성장을 뒷받침하고 있습니다. 2023년 4월 11일, Neil O'Brien 보건상은 Policy Exchange에서 흡연률 감소 및 미성년자 VAPE 대처에 관한 정부 계획에 대해 연설을 실시했습니다.
OTC 니코틴 대체 요법 수요 증가
IMARC Group에 따르면 2023년 세계 OTC 의약품 산업 규모는 1,687억 달러였습니다. 시장을 추진하는 주요 요인 중 하나는 OTC 니코틴 치환제에 대한 수요가 증가하는 것입니다. 이 껌은 처방전 없이 자체 투여가 가능한 쉽게 입수 가능한 OTC 솔루션입니다. 이 껌이 의료 도움을 요구하지 않고 금연하려는 사람들의 최선의 선택으로 인기가 있는 것은 그 입수의 용이성 및 사용의 용이성 때문입니다. 사람들은 헬스케어에 적극적이었고 니코틴 껌 시장 전망은 밝습니다. 게다가, 2024년 1월 24일, 오디샤 주 커탁에 있는 Sri Ram Chandra Bhanja(SCB) Dental College and Hospital에서 실시한 임상시험에서 행동요법과 조합했을 경우의 니코틴 치환 요법(NRT)의 현저한 유효성이 발표되어, 금연의 대처에 큰 돌파구가 나타났습니다.
기술 진보 및 제품 혁신
니코틴 대체 요법의 처방 및 투여에 대한 지속적인 기술 개선과 제품 혁신은 시장 성장을 뒷받침하고 있습니다. 니코틴 껌 기업은 제품의 효율성과 사용자 경험을 향상시키기 위해 연구개발(R&D) 활동에 자금을 투자하고 있습니다. 향상된 맛과 독특한 전달 시스템과 같은 혁신을 통해 사용자는 이러한 껌을 채택했습니다. 게다가, 니코틴 중독과 금단 증상의 과정에 대한 이해가 깊어진 것은 보다 효율적인 껌 제형을 만드는데 도움이 됩니다. 보다 효율적인 금연 솔루션에 대한 수요 증가는 니코틴 껌 시장의 성장을 뒷받침하고 있습니다. 이 외에도 이 시장의 기업은 공인 당국으로부터 제품 승인을 받고 있습니다. 예를 들어, Perrigo Company plc(PRGO)는 2023년 5월 16일에 니코틴 코팅된 민트로젠지 2mg 및 4mg OTC의 최종 승인을 식품 의약국(FDA)으로부터 취득하였습니다. 이 제품은 금연을 시도하는 소비자의 금단 증상을 완화하는 데 도움이 됩니다. 또한 니콜릿 코팅 아이스 민트로젠지와 동등한 제품으로 소매점의 스토어 브랜드 라벨로 판매됩니다.
목차
제1장 서문
제2장 조사 범위 및 조사 방법
조사의 목적
이해관계자
데이터 소스
1차 정보
2차 정보
시장 추정
상향식 접근
하향식 접근
조사 방법
제3장 주요 요약
제4장 서문
개요
주요 업계 동향
제5장 세계의 니코틴 껌 시장
시장 개요
시장 실적
COVID-19의 영향
시장 예측
제6장 시장 내역 : 유형별
2 Mg 니코틴 껌
4 Mg 니코틴 껌
6 Mg 니코틴 껌
제7장 시장 내역 : 용도별
이탈 클리닉
의료 행위
개인 흡연자
기타
제8장 시장 내역 : 유통 채널별
소매 약국
전문점
온라인 스토어
기타
제9장 시장 내역 : 지역별
북미
미국
캐나다
아시아태평양
중국
일본
인도
한국
호주
인도네시아
기타
유럽
독일
프랑스
영국
이탈리아
스페인
러시아
기타
라틴아메리카
브라질
멕시코
기타
중동 및 아프리카
시장 내역 : 국가별
제10장 SWOT 분석
개요
강점
약점
기회
위협
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
개요
구매자의 협상력
공급기업의 협상력
경쟁도
신규 참가업체의 위협
대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
시장 구조
주요 기업
주요 기업 프로파일
British American Tobacco
Cambrex Corporation
GlaxoSmithKline
ITC Limited
Novartis
Johnson & Johnson Services
Perrigo
Pfizer
Takeda Pharmaceutical Company
AJY
영문 목차
영문목차
The global nicotine gum market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4% during 2025-2033. There are various factors that are responsible for the growth of the global market, which include smoking cessation initiatives and heightened health awareness, rising demand for convenient over the counter (OTC) nicotine replacement therapies. Technological innovations for enhancing product efficacy also add significant value to the market.
Nicotine Gum Market Analysis:
Major Market Drivers: The increasing awareness about health risks associated with smoking, along with various smoking cessation initiatives worldwide, are acting as growth-inducing factors.
Key Market Trends: There is a rise in the demand for over the counter (OTC) nicotine replacement therapies. This, coupled with the enhanced convenience and accessibility of the product among individuals seeking to quit smoking, are supporting the market growth.
Geographical Trends: According to the report, North America enjoys a leading position in the market due to the rising number of health-conscious consumers.
Competitive Landscape: Top players in the nicotine gum industry are British American Tobacco, Cambrex Corporation, GlaxoSmithKline, ITC Limited, Johnson & Johnson Services, Novartis, Perrigo, Pfizer, Takeda Pharmaceutical Company, among many others.
Challenges and Opportunities: Challenges include the need to overcome social stigmas associated with smoking cessation aids and ensure proper education about the role of nicotine gum in the quitting process. Nonetheless, nicotine gum market recent opportunities are technological advancements and collaborations among companies to address smoking-related health issues.
Nicotine Gum Market Trends:
Smoking Cessation Initiatives and Health Awareness
Global efforts to reduce smoking, along with rising health awareness, are propelling the market expansion. People are actively looking for effective strategies to quit smoking as awareness about health risks connected with smoking increases among them. Nicotine gum is a smoking cessation aid that helps users manage the symptoms of withdrawal by releasing nicotine gradually and under control. In addition, various smoking cessation programs by healthcare organizations and regulatory authorities has created a favorable atmosphere for nicotine gum demand. The rising acceptance of this gum as an essential component of smoking cessation treatments due to the emphasis on public health and the ongoing efforts to eliminate smoking is impelling the market growth. On 11 April 2023, Neil O'Brien, Health Minister, delivered a speech at Policy Exchange on government plans to cut smoking rates and tackle underage vaping,
Growing Demand for OTC Nicotine Replacement Therapies
As per the IMARC Group, in 2023, the size of the OTC medication industry worldwide was US$ 168.7 Billion. One of the main factors propelling the market is the rising demand for OTC nicotine replacement medicines. This gum is an easily available OTC solution that enables users to self-administer therapy without a prescription. This gum's popularity as a top option for people trying to stop smoking without seeking medical help is due to its accessibility and ease of usage. People are becoming more proactive in managing their health, which is offering a positive nicotine gum market outlook. Furthermore, on 24 January 2024, in a significant breakthrough for tobacco cessation efforts, a clinical trial conducted at Sri Ram Chandra Bhanja (SCB) Dental College and Hospital in Cuttack, Odisha, unveiled the remarkable efficacy of nicotine replacement therapy (NRT) when combined with behavioral therapy.
Technological Advancements and Product Innovation
Continuous technological improvements and product innovations in the formulation and administration of nicotine replacement therapies are bolstering the market growth. Nicotine gum companies are spending money on research and development (R&D) activities to enhance the effectiveness of product as well as user experience. Users are adopting these gums owing to innovations like enhanced flavors and unique delivery systems. In addition, enhanced understanding of nicotine addiction and withdrawal processes are benefiting in the creation of gum formulations that are more efficient. The escalating demand for more efficient smoking cessation solutions is bolstering the nicotine gum market growth. Besides this, companies in the market are getting product approvals from the recognized authorities. For instance, Perrigo Company plc (PRGO) received final approval from the Food Drug Administration (FDA) for nicotine coated mint lozenges 2 mg and 4 mg OTC on 16 May 2023. The product helps in reducing withdrawal symptoms in consumers who are trying to quit smoking. Moreover, it will be marketed under retailer's store brand labels as a comparable offering to Nicorette coated ice mint lozenge.
Nicotine Gum Market Segmentation:
Breakup by Type:
2 Mg Nicotine Gum
4 Mg Nicotine Gum
6 Mg Nicotine Gum
2 mg nicotine gum accounts for the majority of the market share
Those looking to cut back on their nicotine intake during their journey to quit smoking can find 2 mg category a suitable choice. 2mg nicotine gum is an ideal alternative for controlling withdrawal symptoms while progressively weaning off nicotine dependence, making it the perfect choice among light to moderate smokers. Furthermore, it is advised for people who need a step-down strategy and in the early phases of quitting in order to enable a more regulated shift to a life free of nicotine.
Breakup by Application:
Withdrawal Clinics
Medical Practice
Individual Smokers
Others
Medical practice holds the largest share of the industry
Nicotine gums are used in more comprehensive smoking cessation programs in medical settings. Physicians may recommend this gum to patients as part of individualized smoking cessation regimens or during routine consultations. The progressive and regulated release of nicotine from the gum is consistent with evidence-based therapies. In the medical practice application, the importance of healthcare professionals in helping people quit is emphasized, along with the health advantages and individualized assistance that come with using nicotine gum.
Breakup by Distribution Channel:
Retail Pharmacies
Specialty Stores
Online Stores
Others
Retail pharmacies represent the leading market segment
Nicotine gums are readily available at retail pharmacies. Consumers in search of smoking cessation products can easily locate them in close proximity to their homes. This gum is easily available and pharmacists can offer their advice related to medication, which makes it a favored option for those seeking person-to-person support and quick access to quit smoking products.
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest nicotine gum market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for nicotine gum.
North America stands as a significant market due to robust smoking cessation efforts, heightened health awareness, and a substantial consumer base. The region has a well-established healthcare infrastructure and proactive regulatory measures that contribute to the popularity of these gums as a preferred smoking cessation aid. In addition, there is an increase in the number of individuals seeking effective solutions to quit smoking in the North America region. Besides this, the wide availability of these gum across various distribution channels including retail pharmacies and online stores, assists in increasing nicotine gum market revenue. On 18 March 2024, Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the completion of a 5-year, US$ 100-Million-dollar investment strategy, one year ahead of schedule. The project adds more than 150,000 square-feet of capacity and capability expansions across 70% of its North American and European drug development and manufacturing network, which will be completed by the end of 2024. The investments span all scales of clinical and commercial drug substance manufacturing and include advanced technologies to solve for challenges related to complex molecules.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the nicotine gum industry include British American Tobacco, Cambrex Corporation, GlaxoSmithKline, ITC Limited, Johnson & Johnson Services, Novartis, Perrigo, Pfizer, Takeda Pharmaceutical Company.
Key players in the market are engaging in strategic initiatives that are focused on product innovation, marketing, and collaborative efforts. Continuous R&D investments by key manufacturers aim to enhance the effectiveness and appeal of the product formulations. These companies leverage technological advancements to create novel delivery mechanisms, improved flavors, and better taste masking, meeting consumer preferences and driving market growth. Moreover, robust marketing campaigns and partnerships with healthcare organizations contribute to the rising awareness about smoking cessation benefits among individuals while expanding the consumer base. Collaborative efforts between industry stakeholders and regulatory bodies ensure compliance with health standards and foster a positive market environment. On 3 July 2023, Haleon, the world's biggest standalone consumer health business, explored the sale of its nicotine gum business as it aims to streamline its business. The company is working with an adviser to find potential suitors for its Nicotinell brand of nicotine gum, which could be worth about US$ 800 Million in sales.
Key Questions Answered in This Report
1.What was the value of the global nicotine gum market in 2024?
2.At what CAGR is the nicotine gum market projected to grow over the forecast period 2025-2033?
3.What are the key factors driving the nicotine gum market?
4.Which is the leading segment based on type in the nicotine gum market?
5.Which region accounts for the largest nicotine gum market share?
6.Which are the leading companies in the global nicotine gum market?
